Skip to content
Meta-analysis

Stage-Dependent Cognitive Effects of a Multinutrient Intervention in Alzheimer's Disease: A Stage-Stratified Meta-Analysis.

Sep 2026 · Journal of Visualized Experiments · Vol 235 · 0 citations
Medicine

TL;DR

A specific multinutrient intervention provides precursors and cofactors for synaptic membrane synthesis and is compatible with a potential early-stage signal, but the small evidence base, lack of replication across stages, and manufacturer sponsorship warrant cautious interpretation.

Abstract

A specific multinutrient intervention provides precursors and cofactors for synaptic membrane synthesis. Randomized trials across the Alzheimer's disease (AD) continuum have reported mixed findings. We conducted a systematic review and stage-stratified meta-analysis of randomized, placebo-controlled trials. MEDLINE, Embase, CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform were searched through February 28, 2026. Disease stage was prespecified as an effect modifier. Standardized mean differences (SMDs; Hedges' g) were synthesized using restricted maximum likelihood random-effects models. Four trials met the inclusion criteria; three contributed to the quantitative synthesis (analyzed n = 906). Souvenir I was retained for qualitative synthesis because its distinct co-primary outcomes and reporting did not permit a compatible SMD for the prespecified pooled analysis. The exploratory pooled cognitive effect was small and not significant (SMD = 0.08; 95% CI, -0.09 to 0.26; p = 0.35; I2 = 41.8%). For biomarker-confirmed prodromal AD, the 24-month primary neuropsychological test battery (NTB) 5-item composite endpoint showed a small, nonsignificant effect (SMD = 0.16; 95% CI, -0.08 to 0.41; original trial p = 0.166). The primary NTB memory endpoint in mild, drug-naive AD showed a small effect (SMD = 0.21; 95% CI, -0.06 to 0.49; original longitudinal-model p = 0.023), whereas the primary Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) endpoint in treated mild-to-moderate AD showed no benefit (SMD = -0.06; 95% CI, -0.25 to 0.13; p = 0.513). At 36 months, the LipiDiDiet extension reported significant differences in the NTB 5-item composite, clinical dementia rating - sum of boxes (CDR-SB), memory, and brain-volume outcomes. The intervention was well tolerated. The evidence is compatible with a potential early-stage signal, but the small evidence base, lack of replication across stages, and manufacturer sponsorship warrant cautious interpretation.

View source

Similar papers

Review Open access Sep 2026

Lithium exposure and risk of dementia and Alzheimer's disease: A systematic review and meta-analysis.

Lithium exposure was consistently associated with reduced dementia risk, and the magnitude, consistency, and biological plausibility support lithium as a promising candidate for dementia prevention research.

Lorenzo Campedelli, Andrea Cicoli, M. Lastretti et al. · 0 citations
Review Open access Oct 2026

Luteolin for Alzheimer's disease and related cognitive impairment: a systematic review and meta-analysis of efficacy and molecular mechanisms

The multifactorial pathogenesis of Alzheimer's disease (AD) renders conventional single-target therapies largely ineffective. Luteolin, a natural flavonoid, has demonstrated promising pleiotropic neuroprotective potential. This study aims to systematically evaluate the preclinical efficacy and multi-target mechanis...

Ji-Xuan Xin, Xi-Lai Teng, Hong-Yan Su et al. · 0 citations
Review Open access Sep 2026

Non-pharmacological interventions for cognitive function improvement in patients with Alzheimer's disease: a best evidence summary

Objective This study aimed to systematically retrieve, analyze, and synthesize evidence on non-pharmacological interventions to improve overall cognitive function in patients with Alzheimer's disease (AD), providing evidence-based references for selecting and optimizing these interventions. Methods This review followed...

Na-Na Wang, L. Dang, W. Chang et al. · 0 citations
Review Open access Aug 2026

Effects of Exercise Interventions on Peripheral Brain-Derived Neurotrophic Factor: An Umbrella Meta-Analysis Across Clinical and Healthy Populations

Circulating BDNF does not directly establish central BDNF engagement or enhanced neuroplasticity, and current review-level evidence does not establish a universal response, clinical benefit, superior modality, or optimal dose.

Mesut Süleymanoğulları, Cemre Didem Eyipınar, R. Muntean et al. · 0 citations
Review Open access Oct 2026

Examining the links between vitamin C and schizophrenia spectrum disorders: a systematic review and meta-analysis on circulating levels and supplementation outcomes

Introduction Schizophrenia (SCZ) is a debilitating psychiatric condition characterized by psychotic symptoms such as hallucinations, delusions, and disorganized thought. Recent evidence suggests its association with deficiency of various micronutrients. Vitamin C (vitC) is a key endogenous metabolite with potent antiox...

Gaatha Suresh, J. G. Chengaiyan, Fatemeh Dabaghzadeh et al. · 0 citations
Review Sep 2026

The efficacy of donepezil combination therapy strategies in Alzheimer's disease: A systematic review and network meta-analysis.

BackgroundAlzheimer's disease (AD) remains a therapeutic challenge, and adding other agents to donepezil may offer additional benefits.ObjectiveThis network meta-analysis aimed to compare the efficacy of donepezil-based combination therapies versus donepezil monotherapy in patients with AD.MethodsWe searched PubMed, Em...

Xin-Yue Ning, Yan Xiao, Nan Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.